Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
353 studies found for:    "Oligodendroglioma"
Show Display Options
Rank Status Study
21 Completed Prolonged Daily Temozolomide for Low-Grade Glioma
Conditions: Glioma;   Astrocytoma;   Oligodendroglioma
Intervention: Drug: Temozolomide
22 No longer available Expanded Access to ANG1005 for Individual Patients
Conditions: Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Breast Cancer With Recurrent Brain Metastases;   Leptomeningeal Carcinomatosis
Intervention: Drug: ANG1005
23 Completed Topotecan in Treating Patients With Recurrent Brain Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: topotecan hydrochloride
24 Recruiting First in Patient Study for PF-06840003 in Malignant Gliomas
Conditions: Oligodendroglioma;   Astrocytoma;   Malignant Glioma
Intervention: Drug: PF-06840003
25 Recruiting A Prospective Cohort to Study the Effect of Temozolomide on IDH Mutational Low Grade Gliomas
Conditions: Astrocytoma;   Oligodendroglioma;   Oligoastrocytoma
Intervention: Drug: Temozolomide
26 Recruiting Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma
Conditions: Astrocytoma;   Oligodendroglioma;   Oligodendroastrocytoma
Interventions: Radiation: Radiotherapy;   Drug: Temozolomide
27 Recruiting Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas
Conditions: Malignant Gliomas;   Oligodendrogliomas;   Astrocytomas
Intervention: Device: 3 Tesla scanning
28 Recruiting Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors
Conditions: Astrocytoma;   Glioma;   Oligodendroglioma
Interventions: Biological: Hepatitis A Vaccine;   Other: Laboratory Biomarker Analysis;   Biological: Tetanus Toxoid Vaccine;   Biological: Trivalent Influenza Vaccine
29 Active, not recruiting FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma
Conditions: Astrocytoma;   Oligoastrocytoma;   Oligodendroglioma
Intervention:
30 Completed HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas
Conditions: Astrocytoma;   Oligoastrocytoma;   Oligodendroglioma
Intervention: Biological: Peptide vaccine + Poly-ICLC
31 Completed
Has Results
Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
Conditions: Anaplastic Astrocytomas;   Anaplastic Oligodendrogliomas;   Glioblastomas (GBM)
Intervention: Drug: Etirinotecan pegol
32 Terminated Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma
Intervention: Other: MRS Spectroscopy
33 Recruiting Carboplatin in Treating Patients With Recurrent High-Grade Gliomas
Conditions: Adult Anaplastic Astrocytoma;   Adult Anaplastic Oligodendroglioma;   Recurrent Adult Brain Tumor
Interventions: Drug: carboplatin;   Procedure: Surgery
34 Completed Phase II Trial of RAD001 in Patients With Recurrent Low Grade Glioma
Conditions: Low-grade Glioma;   Astrocytoma;   Oligodendroglioma;   Mixed Oligoastrocytoma
Intervention: Drug: RAD001
35 Completed Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: aldesleukin;   Biological: autologous tumor cell vaccine;   Biological: muromonab-CD3;   Biological: sargramostim;   Biological: therapeutic autologous lymphocytes;   Procedure: surgical procedure;   Radiation: radiation therapy
36 Recruiting Clinical Development of MR Spectroscopy and Imaging in Brain Cancers
Conditions: Malignant Gliomas;   Astrocytomas;   Oligodendrogliomas
Interventions: Device: 3 Tesla Scanning;   Device: 7 Tesla Scanning
37 Terminated A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma
Conditions: Glioma;   Astrocytoma;   Oligodendroglioma;   Oligoastrocytoma
Intervention: Drug: Temozolomide and O6-Benzylguanine
38 Recruiting Everolimus With and Without Temozolomide in Adult Low Grade Glioma
Conditions: Low Grade Glioma;   WHO Grade II Astrocytomas;   Oligodendrogliomas;   Mixed Oligoastrocytomas
Interventions: Drug: Everolimus;   Drug: Temozolomide
39 Active, not recruiting Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Intervention: Biological: Toca 511
40 Active, not recruiting Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma
Intervention: Biological: Toca 511

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.